Its the Anesthesiologists Who Are the Best Ones to Run an ICU: Against

Total Page:16

File Type:pdf, Size:1020Kb

Load more

ANAESTHESIA, PAIN & INTENSIVE CARE www.apicareonline.com CONTROVERSIES Its the anesthesiologists who are the best ones to run an ICU: against Carlos R Degrandi Oliveira, MD, MSc, TSA, Santos, Brazil ABSTRACT Carlos R Degrandi Oliveira, Av. Historically the contribution of anesthesiology is undeniable, however, often related Epitácio Pessoa, 131 ap. 104, perioperative practical skills are not the only components of intensive care. Today, the Santos, São Paulo, Brazil skills of a trained intensivist have enormous diversity. Actually too big to be owned 11045-301; by a classic specialty, whatever. Intensive medicine has become a unique, complex Phone: +55 13 991529799; multidisciplinary profession with different backgrounds transcending a host of other E-mail: [email protected] specialties. Anesthesiology could be a leader in some contexts, however, seems to be a leadership to be regained, in other scenarios, intensive medicine is already hopelessly Correspondence: individualized, and stands out. Considering the heterogeneous development and Carlos R Degrandi Oliveira, Av. policies around the world, currently no other specialty is in a position to consider itself Epitácio Pessoa, 131 ap. 104, naturally competent to assume the responsibility of conducting an ICU. Santos, São Paulo, Brazil 11045-301; Key words: Anesthesiology; Care unit, Intensive; Care, Intensive Phone: +55 13 991529799; E-mail: [email protected] Citation: Oliveira CRD. Its the anesthesiologists who are the best ones to run an ICU: Received: 14 Sep 2018 against.Anaesth Pain & Intensive Care 2018;22 Suppl 1:S9-S12 Reviewed: 10 Nov 2018 Corrected & Accepted: 12 Nov 2018 The poliomyelitis epidemic in Copenhagen in the idea of keeping severely ill patients together in 1952 was an early milestone in the creation of the one place.1,2 current intensive care units. Bjorn Ibsen (1915- In the early days of intensive medicine, the main 2007), an anesthesiologist, noted that the negative objectives were to treat the complications resulting pressure respirator commonly used at that time from the prim ary disease: to maintain breathing was unable to provide adequate ventilation to the and circulati on. Specialists in internal medicine, patients’ lungs. Ibsen then administered intermittent nephrology, infectious diseases, neurology and others positive pressure ventilation with the aid of a manual were routinely needed, each covering their own area ventilation bag attached to an endotracheal tube with of expertise.2 a cuff or tracheostomy cannula. Early it was observed that this conduct associated with physiotherapy Anesthesiologists have not always been in leadership. under blood gas control would reduce mortality. In many cases , hospitals wanted more than one Manual ventilation of patients was performed by unit and form ed a group of intensive care units, teams of medical students who took turns and allowed each speciali zing in different surgical and medical the survival of several patients. Subsequently, it was disciplines. This modality had disadvantages. also applied in patients with drug overdoses, tetanus Patient care was fragmented, causing management and chest trauma with improvement in survival. It difficulties. Specialized intensive care units were well was the embryo of the ICU that arose largely as a developed in their field of interest. However, when consequence of the anesthesiologist’s experience patients deve loped problems outside that area of in artificial ventilation and in the application of expertise, they were not adequately treated.2 equipment and techniques for purposes other than The discussio n on the subject passes through the the administration of anesthetics. Epidemics and formation of the intensivist. Currently, despite the other catastrophes of the last century have reinforced recognition of the broad mix of skills required, over S9 ANAESTH, PAIN & INTENSIVE CARE; VOL 22(Suppl) October 2018 the decades, the evolution of intensive medicine comfort and recovery, end of life, pediatric care, training programs has remained highly variable, patient transportation, safety, management and often fragmented and unable to provide a uniform professionalism.6,7 combination of skills and competencies. Anesthesiology includes anesthesia, perioperative Australia was a pioneer in establishing formal care, intensive care medicine, emergency medicine qualifications for intensivists, and the Australian and pain therapy, and is recognized as one of the Faculty of Anaesthesists organized the first leading medical specialties in the treatment of patient examination for intensivists in 1979. In the USA safety issues.8 Because of its history and singularities, and many European countries, several surgical and anesthesiology is the specialty most often linked to medical specialties as well as anesthesiology have intensive medicine.9,10 developed their own training programs resulting in The contribution of anesthesiology is undeniable, intensive care subspecialties within a major specialty. however, often related perioperative practical skills In the Nordic countries and in Italy, intensive are not the only components of intensive care. Today, medicine has developed as a natural extension of the skills of a trained intensivist have enormous anesthesiology.3 diversity. In fact too big to be owned by a classic Intensive medicine was established as a primary specialty, whatever. specialty in Spain and Switzerland. In 10 countries The days have passed, and a good intubation ability of the European Union, intensive medicine can be has not long been a good anesthesiologist, nor a good practiced as a specific qualification with a common intensivist. The competence needed to cope with the training program for specialists with certification critical conditions gradually changed and different in several basic disciplines (anesthesiology, cardiac skills, apparently belonging to other specialties, surgery, cardiology, internal medicine, neurology, became crucial in the practice of intensive medicine.11 neurosurgery, pediatrics, respiratory medicine Although intensivists may have a different specialty and surgery). A specific qualification is an area of or specific field of interest, they should have broad specialization as well as a major specialty qualification knowledge of the skills needed to treat the patient in which extra specialization is required outside the as a whole, and these have increased dramatically mainstream field to provide high quality patient in recent years. Intensivists routinely perform care. In the remaining 17 countries of the European hemofiltration, ultrasound, ECMO, bronchoscopy, Union and the other two countries in the economic parenteral nutrition, antibiotic therapy and many area, intensive medicine is part of the anesthesiology other complex treatments in their daily practice. training program, among others, with different training periods ranging from 6 to 24 months. The Anesthesiologists-intensivists are in small numbers, training program for anesthesiology also varies from as is the case in the USA. In 2001 less than 4% of 36 to 72 months in these countries.4 the 25,000 board-certified anesthesiologists have the Certificate of Special Competence in Critical Care. The United Kingdom is a pioneer in Europe in Of the 7,800 members of the Society of Critical Care the development of competency-based training Medicine, approximately 35% are internists, 25% are in intensive care medicine with access to various surgeons, and only 12% are anesthesiologists.12 Of the basic skills. This approach emphasizes skills and 56,345 physicians certified in anesthesiology in 2016, competencies, not just knowledge.3,5 only 2,153 (3.8%) are also diplomates in critical care Competency-based training has been supported by medicine.13,14 the European Union, and the European Society of According to some authors intensive medicine in Intensive Care Medicine has played a leading role the USA suffers from a complex identity crisis. To in its development. In this case, the duration of begin with, physicians of other specialties tend to the training depends on the individual time spent be ambiguous about the role of intensivists, and the on the achievement of each specific competency. general population is not aware of their duties. In The CoBaTrICE (International Competency Based contrast to traditional specialties such as cardiology Training Program in Intensive Care Medicine in or gastroenterology where responsibilities are Europe) focused on writing a competency-based generally known to the lay public, or in contrast training program to set the minimum standard of to newly developed specialties such as emergency knowledge, skills and attitudes. This standard includes medicine, the enigmatic roles of an intensivist may resuscitation, diagnosis, disease management, differ depending on a primary specialty, the patient interventions, procedures, perioperative care, population or even between ICUs within the same S10 ANAESTH, PAIN & INTENSIVE CARE; VOL 22(Suppl) October 2018 hospital.15 work around the critical patient, being a reference and also an interface between the patient and other The obstacles of primary intensive medicine are many. specialists when the skills of a single professional are The standardization of education, accreditation, insufficient. Their intensive medicine training can current educational arrangement of the various be built on other specialties such as anesthesiology, specialties (anesthesiology, internal medicine, surgery, as is often the case
Recommended publications
  • Speakers and Topics

    Speakers and Topics

    SPEAKERS AND TOPICS SALZBURG WEILL CORNELL SEMINAR ANESTHESIOLOGY AND INTENSIVE CARE Sunday, October 18 – Saturday, October 24, 2020 Schloss Arenberg, Salzburg, Austria Course Director: Hugh C. Hemmings Jr., MD, PhD, FRCA Co-Course Director: Klaus Markstaller, MD Co-Course Director: Kane O. Pryor, MD Co-Course Director: Peter Marhofer, MD SPEAKERS AND TOPICS: Meghann M. Fitzgerald, MD Assistant Professor of Clinical Anesthesiology Weill Cornell Medical College Assistant Attending Anesthesiologist NewYork-Presbyterian Hospital Weill Cornell Medicine Anesthesiology New York, NY USA • Robotic Cardiac Surgery • Blood Management in Cardiac Surgery • TAAA Repair Lukas Kirchmair, MD, PD, DESA, EDRA Department of Anesthesiology and Intensive Care District Hospital Schwaz Schwaz Austria • Polytrauma Management Rudolf Likar, MD, MSc Professor Head, Department of Anesthesiology and Intensive Care General Hospital Klagenfurt Klagenfurt am Woerthersee Austria • Invasive Methods in Cancer Pain • Invasive Methods in Low Back Pain © Open Medical Institute 2020 SPEAKERS AND TOPICS Peter Marhofer, MD Professor of Anesthesia and Intensive Care Medicine Department of Anesthesia and Intensive Care Medicine Medical University of Vienna Vienna Austria • Principles of Regional Anaesthesia I • Principles of Regional Anaesthesia II • Ultrasound in Anaesthesia and Intensive Care Medicine I • Ultrasound in Anaesthesia and Intensive Care Medicine II Rohan Panchamia, MD Assistant Professor of Clinical Anesthesiology Weill Cornell Medical College Assistant Attending
  • COVID-19 Pneumonia: Different Respiratory Treatment for Different Phenotypes? L

    COVID-19 Pneumonia: Different Respiratory Treatment for Different Phenotypes? L

    Intensive Care Medicine EDITORIAL Un-edited accepted proof COVID-19 pneumonia: different respiratory treatment for different phenotypes? L. Gattinoni1, D. Chiumello2, P. Caironi3, M. Busana1, F. Romitti1, L. Brazzi4, L. Camporota5 Affiliations: 1Department of Anesthesiology and Intensive Care, Medical University of GöttinGen 4Department of Anesthesia, Intensive Care and Emergency - 'Città della Salute e della Scienza’ Hospital - Turin 5Department of Adult Critical Care, Guy’s and St Thomas’ NHS Foundation Trust, Health Centre for Human and Applied Physiological Sciences - London Corresponding author: Luciano Gattinoni Department of Anesthesiology and Intensive Care, Medical University of Göttingen, Robert-Koch Straße 40, 37075, Göttingen, Germany Conflict of interests: The authors have no conflict of interest to disclose NOTE: This article is the pre-proof author’s accepted version. The final edited version will appear soon on the website of the journal Intensive Care Medicine with the following DOI number: DOI 10.1007/s00134-020-06033-2 1 Gattinoni L. et al. COVID-19 pneumonia: different respiratory treatment for different phenotypes? (2020) Intensive Care Medicine; DOI: 10.1007/s00134-020-06033-2 Intensive Care Medicine EDITORIAL Un-edited accepted proof The Surviving Sepsis CampaiGn panel (ahead of print, DOI: 10.1007/s00134-020-06022-5) recently recommended that “mechanically ventilated patients with COVID-19 should be managed similarly to other patients with acute respiratory failure in the ICU.” Yet, COVID-19 pneumonia [1], despite falling in most of the circumstances under the Berlin definition of ARDS [2], is a specific disease, whose distinctive features are severe hypoxemia often associated with near normal respiratory system compliance (more than 50% of the 150 patients measured by the authors and further confirmed by several colleagues in Northern Italy).
  • Intensive Care Medicine in 10 Years

    Intensive Care Medicine in 10 Years

    BOOKS,FILMS,TAPES &SOFTWARE are difficult to read, the editing is inconsis- tory for critical care medicine. The book is initiate a planning process for leaders who tent, and the content that was omitted indi- divided into sections entitled “Setting the recognize the imperative for change and ad- cates that “efforts to bring this work from Stage,” “Diagnostic, Therapeutic, and In- aptation in critical care. Accordingly, I rec- conception to fruition in less than one year” formation Technologies 10 Years From ommend this book to individuals and groups (as stated in the book’s acknowledgments Now,” “How Might Critical Care Medicine engaged in all aspects of critical care man- section) prevented this book from being a Be Organized and Regulated?” “Training,” agement, now and in the future. “gold standard” text. and “The Critical Care Agenda.” Each sec- J Christopher Farmer MD tion consists of a series of essays/chapters Marie E Steiner MD MSc Department of Medicine that discuss various aspects of the topic, and Department of Pediatrics Mayo Clinic all the sections have solid scientific support Divisions of Pulmonary/ Rochester, Minnesota and bibliographies. The individual topics Critical Care and Hematology/ span the entire range of critical-care clinical Oncology/Blood and Marrow The author reports no conflict of interest related practice, administration, quality and safety, Transplantation to the content of this book review. and so forth. The contributors are acknowl- University Children’s Hospital, Fairview edged senior clinical and scientific leaders University of Minnesota Mechanical Ventilation: Physiological in critical care medicine from around the Minneapolis, Minnesota and Clinical Applications, 4th edition.
  • Intravenous Immunoglobulin Fails to Improve ARDS in Patients

    Intravenous Immunoglobulin Fails to Improve ARDS in Patients

    Prohaska et al. Journal of Intensive Care (2018) 6:11 DOI 10.1186/s40560-018-0278-8 RESEARCH Open Access Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy Stefanie Prohaska1, Andrea Schirner1, Albina Bashota1, Andreas Körner1, Gunnar Blumenstock2 and Helene A. Haeberle1* Abstract Background: Acute respiratory distress syndrome (ARDS) is associated with high mortality rates. ARDS patients suffer from severe hypoxemia, and extracorporeal membrane oxygenation (ECMO) therapy may be necessary to ensure oxygenation. ARDS has various etiologies, including trauma, ischemia-reperfusion injury or infections of various origins, and the associated immunological responses may vary. To support the immunological response in this patient collective, we used intravenous IgM immunoglobulin therapy to enhance the likelihood of pulmonary recovery. Methods: ARDS patients admitted to the intensive care unit (ICU) who were placed on ECMO and treated with (IVIG group; n = 29) or without (control group; n = 28) intravenous IgM-enriched immunoglobulins for 3 days in the initial stages of ARDS were analyzed retrospectively. Results: The baseline characteristics did not differ between the groups, although the IVIG group showed a significantly reduced oxygenation index compared to the control group. We found no differences in the length of ICU stay or ventilation parameters. We did not find a significant difference between the groups for the extent of inflammation or for overall survival. Conclusion: We conclude that administration
  • Characteristics and Risk Factors for Intensive Care Unit Cardiac Arrest in Critically Ill Patients with COVID-19—A Retrospective Study

    Characteristics and Risk Factors for Intensive Care Unit Cardiac Arrest in Critically Ill Patients with COVID-19—A Retrospective Study

    Journal of Clinical Medicine Article Characteristics and Risk Factors for Intensive Care Unit Cardiac Arrest in Critically Ill Patients with COVID-19—A Retrospective Study Kevin Roedl 1,* , Gerold Söffker 1, Dominic Wichmann 1 , Olaf Boenisch 1, Geraldine de Heer 1 , Christoph Burdelski 1, Daniel Frings 1, Barbara Sensen 1, Axel Nierhaus 1 , Dirk Westermann 2, Stefan Kluge 1 and Dominik Jarczak 1 1 Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany; [email protected] (G.S.); [email protected] (D.W.); [email protected] (O.B.); [email protected] (G.d.H.); [email protected] (C.B.); [email protected] (D.F.); [email protected] (B.S.); [email protected] (A.N.); [email protected] (S.K.); [email protected] (D.J.) 2 Department of Interventional and General Cardiology, University Heart Centre Hamburg, 20246 Hamburg, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-40-7410-57020 Abstract: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causing the coron- avirus disease 2019 (COVID-19) led to an ongoing pandemic with a surge of critically ill patients. Very little is known about the occurrence and characteristic of cardiac arrest in critically ill patients Citation: Roedl, K.; Söffker, G.; with COVID-19 treated at the intensive care unit (ICU). The aim was to investigate the incidence Wichmann, D.; Boenisch, O.; de Heer, and outcome of intensive care unit cardiac arrest (ICU-CA) in critically ill patients with COVID-19. G.; Burdelski, C.; Frings, D.; Sensen, This was a retrospective analysis of prospectively recorded data of all consecutive adult patients B.; Nierhaus, A.; Westermann, D.; with COVID-19 admitted (27 February 2020–14 January 2021) at the University Medical Centre et al.
  • Rapid Evidence Review

    Rapid Evidence Review

    Rapid Evidence Review Clinical evidence for the use of intravenous immunoglobulin in the treatment of COVID- 19 Version 2, 14th May 2020 1 Prepared by the COVID-19 Evidence Review Group with clinical contribution from Dr. Niall Conlon, Consultant Immunologist, St. James Hospital, Dr. Mary Keogan, Clinical Lead National Clinical Programme for Pathology & Consultant Immunologist, Beaumont Hospital. Key changes between version 1 and version 2 (14th May 2020) A number of case reports describing the use of IVIG are included in this version and 2 additional studies which focused specifically on the use of IVIG in patients with COVID-19 – one case series and one retrospective cohort study (available as a pre-print). A number of guidelines have included a reference to IVIG, but the general consensus is not to use IVIG. The recent reports of Kawasaki Disease in children with COVID-19 highlight the role of IVIG and aspirin to treat this condition and supporting evidence of its benefit are available from 2 case reports and one case series. The COVID-19 Evidence Review Group for Medicines was established to support the HSE in managing the significant amount of information on treatments for COVID-19. This COVID-19 Evidence Review Group is comprised of evidence synthesis practitioners from across the National Centre for Pharmacoeconomics (NCPE), Medicines Management Programme (MMP) and the National Medicines Information Centre (NMIC). The group respond to queries raised via the Office of the CCO, National Clinical Programmes and the Department of Health and respond in a timely way with the evidence review supporting the query.
  • Surviving Sepsis Campaign Guidelines for COVID-19

    Surviving Sepsis Campaign Guidelines for COVID-19

    DISCLAIMER. The information contained herein is subject to change. The final version of the article will be published as soon as approved on ccmjournal.org. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) Waleed Alhazzani1,2, Morten Hylander Møller3,4, Yaseen M. Arabi5, Mark Loeb1,2, Michelle Ng Gong6, Eddy Fan7, Simon Oczkowski1,2, Mitchell M. Levy8,9, Lennie Derde10,11, Amy Dzierba12, Bin Du13, Michael Aboodi6, Hannah Wunsch14,15, Maurizio Cecconi16,17, Younsuck Koh18, Daniel S. Chertow19, Kathryn Maitland20, Fayez Alshamsi21, Emilie Belley-Cote1,22, Massimiliano Greco16,17, Matthew Laundy23, Jill S. Morgan24, Jozef Kesecioglu10, Allison McGeer25, Leonard Mermel8, Manoj J. Mammen26, Paul E. Alexander2,27, Amy Arrington28, John Centofanti29, Giuseppe Citerio30,31, Bandar Baw1,32, Ziad A. Memish33, Naomi Hammond34,35, Frederick G. Hayden36, Laura Evans37, Andrew Rhodes38 Affiliations 1 Department of Medicine, McMaster University, Hamilton, Canada 2 Department of Health Research Methods, Evidence, and Impact, McMaster University, Canada 3 Copenhagen University Hospital Rigshospitalet, Department of Intensive Care, Copenhagen, Denmark 4 Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI) 5 Intensive Care Department, Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia 6 Department of Medicine, Montefiore Healthcare
  • Best-Practice Igm- and Iga-Enriched Immunoglobulin Use in Patients with Sepsis

    Best-Practice Igm- and Iga-Enriched Immunoglobulin Use in Patients with Sepsis

    Nierhaus et al. Ann. Intensive Care (2020) 10:132 https://doi.org/10.1186/s13613-020-00740-1 REVIEW Open Access Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis Axel Nierhaus1,2* , Giorgio Berlot3, Detlef Kindgen‑Milles4, Eckhard Müller5 and Massimo Girardis6 Abstract Background: Sepsis is a life‑threatening organ dysfunction caused by a dysregulated host response to infection. Despite treatment being in line with current guidelines, mortality remains high in those with septic shock. Intrave‑ nous immunoglobulins represent a promising therapy to modulate both the pro‑ and anti‑infammatory processes and can contribute to the elimination of pathogens. In this context, there is evidence of the benefts of immuno‑ globulin M (IgM)‑ and immunoglobulin A (IgA)‑enriched immunoglobulin therapy for sepsis. This manuscript aims to summarize current relevant data to provide expert opinions on best practice for the use of an IgM‑ and IgA‑enriched immunoglobulin (Pentaglobin) in adult patients with sepsis. Main text: Sepsis patients with hyperinfammation and patients with immunosuppression may beneft most from treatment with IgM‑ and IgA‑enriched immunoglobulin (Pentaglobin). Patients with hyperinfammation present with phenotypes that manifest throughout the body, whilst the clinical characteristics of immunosuppression are less clear. Potential biomarkers for hyperinfammation include elevated procalcitonin, interleukin‑6, endotoxin activity and C‑reactive protein, although thresholds for these are not well‑defned. Convenient biomarkers for identifying patients in a stage of immune‑paralysis are still matter of debate, though human leukocyte antigen–antigen D related expression on monocytes, lymphocyte count and viral reactivation have been proposed. The timing of treatment is potentially more critical for treatment efcacy in patients with hyperinfammation compared with patients who are in an immunosuppressed stage.
  • Recommendations for End-Of-Life Care in the Intensive Care Unit: a Consensus Statement by the American College of Critical Care Medicine

    Recommendations for End-Of-Life Care in the Intensive Care Unit: a Consensus Statement by the American College of Critical Care Medicine

    Special Articles Recommendations for end-of-life care in the intensive care unit: A consensus statement by the American College of Critical Care Medicine Robert D. Truog, MD, MA; Margaret L. Campbell, PhD, RN, FAAN; J. Randall Curtis, MD, MPH; Curtis E. Haas, PharmD, FCCP; John M. Luce, MD; Gordon D. Rubenfeld, MD, MSc; Cynda Hylton Rushton, PhD, RN, FAAN; David C. Kaufman, MD Background: These recommendations have been developed to to die, and between consequences that are intended vs. those that improve the care of intensive care unit (ICU) patients during the are merely foreseen (the doctrine of double effect). Improved dying process. The recommendations build on those published in communication with the family has been shown to improve pa- 2003 and highlight recent developments in the field from a U.S. tient care and family outcomes. Other knowledge unique to end- perspective. They do not use an evidence grading system because of-life care includes principles for notifying families of a patient’s most of the recommendations are based on ethical and legal death and compassionate approaches to discussing options for principles that are not derived from empirically based evidence. organ donation. End-of-life care continues even after the death of Principal Findings: Family-centered care, which emphasizes the patient, and ICUs should consider developing comprehensive the importance of the social structure within which patients are bereavement programs to support both families and the needs of embedded, has emerged as a comprehensive ideal for managing the clinical staff. Finally, a comprehensive agenda for improving end-of-life care in the ICU.
  • Download Download

    Download Download

    This article has been retracted: please see INNOVATIONS in pharmacy retraction policy (https://pubs.lib.umn.edu/index.php/innovations/policies). This article has been retracted by the Editor and Publisher due to the inappropriate use of previously published work. Commentary PHARMACY PRACTICE Pharmacists in Critical Care AK Mohiuddin, Assistant Professor Department of Pharmacy, World University of Bangladesh, Bangladesh Abstract The beginnings of caring for critically ill patients date back to Florence Nightingale’s work during the Crimean War in 1854, but the subspecialty of critical care medicine is relatively young. The first US multidisciplinary intensive care unit (ICU) was established in 1958, and the American Board of Medical Subspecialties first recognized the subspecialty of critical care medicine in 1986. Critical care pharmacy services began around the 1970s, growing in the intervening 40 years to become one of the largest practice areas for clinical pharmacists, with its own section in the SCCM, the largest international professional organization in the field. During the next decade, pharmacy services expanded to various ICU settings (both adult and pediatric), the operating room, and the emergency department. In these settings, pharmacists established clinical practices consisting of therapeutic drug monitoring, nutrition support, and participation in patient care rounds. Pharmacists also developed efficient and safe drug delivery systems with the evolution of critical care pharmacy satellites and other innovative programs. In the 1980s, critical care pharmacists designed specialized training programs and increased participation in critical care organizations. The number of critical care residencies and fellowships doubled between the early 1980s and the late 1990s. Standards for critical care residency were developed, and directories of residencies and fellowships were published.
  • Chronic Critical Illness: Are We Saving Patients Or Creating Victims?

    Chronic Critical Illness: Are We Saving Patients Or Creating Victims?

    REVIEW ARTICLE Sergio Henrique Loss1,2, Diego Silva Leite Nunes1, Oellen Stuani Franzosi1,3, Gabriela Soranço Chronic critical illness: are we saving patients or Salazar4, Cassiano Teixeira5, Silvia Regina Rios Vieira1,2,6 creating victims? Doença crítica crônica: estamos salvando ou criando vítimas? 1. Postgraduate Program in Medical Sciences, ABSTRACT metabolism, show immunodeficiency, Faculdade de Medicina, Universidade Federal do consume substantial health resources, Rio Grande do Sul - Porto Alegre (RS), Brazil. The technological advancements have reduced functional and cognitive 2. Intensive Care Unit, Hospital de Clínicas de that allow support for organ dysfunction Porto Alegre - Porto Alegre (RS), Brazil. capacity after discharge, create a sizable 3. Department of Nutrition, Hospital de Clínicas have led to an increase in survival rates workload for caregivers, and present high de Porto Alegre - Porto Alegre (RS), Brazil. for the most critically ill patients. Some long-term mortality rates. The aim of this 4. Department of Nutrition, Hospital Mãe de of these patients survive the initial acute review is to report on the most current Deus - Porto Alegre (RS), Brazil. critical condition but continue to suffer evidence in terms of the definition, 5. Faculdade de Medicina, Universidade Federal from organ dysfunction and remain in de Ciências da Saúde de Porto Alegre - Porto pathophysiology, clinical manifestations, Alegre (RS), Brazil. an inflammatory state for long periods of treatment, and prognosis of persistent 6. Department of Internal Medicine, Universidade time. This group of critically ill patients critical illness. Federal do Rio Grande do Sul - Porto Alegre (RS), has been described since the 1980s and Brazil. has had different diagnostic criteria over Keywords: Critical illness; the years.
  • Preoperative Anaesthesiologic

    Preoperative Anaesthesiologic

    Psychiatria Danubina, 2019; Vol. 31, Suppl. 5, pp S745-S749 Medicina Academica Mostariensia, 2019; Vol. 7, No. 1-2, pp 23-27 Review © Medicinska naklada - Zagreb, Croatia PREOPERATIVE ANAESTHESIOLOGIC EVALUATION OF PATIENT WITH KNOWN ALLERGY Željko ýolak1, Mario Pavlek1, Mirabel Mažar1, Sanja Konosiü1, Višnja Ivanþan & Milenko Bevanda2 1University of Zagreb, School of Medicine, Department of Anesthesiology, Reanimatology and Intensive Care Medicine, University Hospital Zagreb, Zagreb, Croatia 2University of Mostar, School of Medicine, Mostar, Bosnia and Herzegovina received: 13.9.2019; revised: 23.10.2019; accepted: 28.11.2019 SUMMARY Anaphylaxis is an unanticipated systemic hypersensitivity reaction which can produce deleterious effects, even death, if not treated promptly. Preventive approach implies taking a thorough anamnesis with the emphasis on previously diagnosed allergies. If an allergic reaction occurred during previous surgery, a detailed documentation of administered anaesthetic agents and drugs would be crucial for the following anaesthesiologic management. Preoperative planning and avoiding cross-reactivity with drugs commonly used during anaesthesia are the key points to prevent an anaphylaxis. In case of emergency surgery when the exact identification of allergens is not possible, premedication prophylaxis should be considered. General measures for prevention of anaphylaxis could be undertaken as well, such as the choice of anaesthesiologic drugs and techniques in the operating theatre adequately equipped for the management